IONS FY 2021 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$810M+11.1% YoY

Gross Profit

$800M98.7% margin

Operating Income

-$30M-3.7% margin

Net Income

-$29M-3.5% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$13M

Stock-Based Comp.

$121M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.8B

Stockholders' Equity

$772M

Cash & Equivalents

$869M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$810M	$729M	+11.1%
Gross Profit	$800M	$717M	+11.5%
Operating Income	-$30M	-$172M	+82.5%
Net Income	-$29M	-$444M	+93.6%